HomeBusiness NewsCircadian Rhythm Sleep Treatment Market Growing Business Factors, Industry Trends, Share, Size,...

Circadian Rhythm Sleep Treatment Market Growing Business Factors, Industry Trends, Share, Size, Growth, Opportunity And Forecast 2034

The global circadian rhythm sleep treatment market, valued at USD 784.7 million in 2024, is projected to grow at a CAGR of 4.7% during the period 2024-2034. Products and therapies designed to treat sleep disorders or irregularities associated with circadian rhythm disorders lead the taurotherapy market.

Get Free Sample Copy of This Report:

Circadian rhythm disorders occur when the body’s internal clock determines when it is time to wake up and go. sleep, not in sync with the environment. An internal clock that repeats itself every 24 hours is called a circadian clock. Circadian rhythms are 24-hour cycles that act as the body’s internal clock and act as a backdrop for important functions and processes. The market serves conditions such as sleep apnea, arrhythmias and other cardiovascular problems that affect sleep by combining aspects of cardiology and sleep medicine.

Key Takeaways from Market Study

  • The global bull therapy market is estimated to be valued at US$ 784.7 billion in 2024.
  • The demand for bull therapy is expected to grow at a 4.7% CAGR between 2024 and 2034.
  • The market value is forecast to reach US$ 1.23 billion by the end of 2034.
  • North America is estimated to account for 34.9% of the global market in 2024.
  • The demand for drugs used in the treatment of circadian rhythms will grow by 4.8% between 2024 and 2034.
  • The North America market is projected to grow at a CAGR of 4.9% by 2034.
  • The East Asian market is projected to grow at a CAGR of 5.6% from 2024 to 2034.

“The global market for circadian rhythm sleep treatment is being driven by the rising prevalence of psychological issues such as anxiety, depression, hypertension, and other ailments associated with lack of sleep. Major factors contributing to circadian rhythm sleep disorder include the aging of the population and the increasing incidence of sedentary lifestyle disorders, particularly diabetes,” says a Fact.MR analyst.

Key Companies Profiled in This Report

  • Vanda Pharmaceuticals, Inc.
  • Akeda Pharmaceutical Company
  • LimitedIdorsia Pharmaceuticals Ltd.
  • VU University Medical
  • CenterNeuraxpharm
  • The Sunbox Company

Increasing Prevalence of CRSDs and Technological Advancements in Chronobiology

Circadian sleep disorders (CRSD) are a group of disorders that disrupt the body’s natural sleep-wake cycle. Several variables such as jet lag, shift work, and increased exposure to artificial light contribute to the prevalence of CRSDs worldwide. This increases the demand for advanced and improved solutions for the diagnosis and treatment of CRSD.

The circadian rhythm sleep therapy market has undergone radical changes due to technological advances in chronobiology and sleep science. Precision methods are increasingly used to regulate and synchronize disturbed sleep-wake cycles. These strategies range from technological personal therapy to adapted therapy that addresses the challenges of change work. Wearable technologies and digital therapies are ushering in a new era of targeted tactics for improving sleep health and improved diagnosis and treatment of CRSD.

  • For example, in December 2020, Vanda Pharmaceutical announced that the US FDA approved HETLIOZ liquid and capsule. dosage forms for the diagnosis of Smith-Magenis syndrome (SMS) in adults and children. It is a developmental disorder that disrupts sleep.

Get Customization on this Report for Specific Research Solutions:

More Valuable Insights on Offer

In its new offering, Fact.MR presents an unbiased analysis of the circadian rhythm treatment market for the period 2018-2023 and forecast statistics for the period 2024-2034.

The study highlights key market insights based on treatment (devices, drugs). , chronotherapy). ), disorder (delayed sleep phase syndrome, advanced sleep phase syndrome, non-24-hour sleep-wake syndrome, irregular sleep-wake disorder, shift-shift disorder, jet lag) and sales channel (plant sales, retail) in six major regions of the world (North America, Latin America, Europe, East Asia, South Asia and Oceania and MEA).


US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com